Skip to main content
Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.620
+0.070 (4.52%)
Nov 21, 2024, 11:10 AM EST - Market open

Entera Bio Revenue

Entera Bio had revenue of $42.00K in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $99.00K, up 607.14% year-over-year.

Revenue (ttm)
$99.00K
Revenue Growth
+607.14%
P/S Ratio
n/a
Revenue / Employee
$5,500
Employees
18
Market Cap
59.67M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022134.00K-437.00K-76.53%
Dec 31, 2021571.00K206.00K56.44%
Dec 31, 2020365.00K129.00K54.66%
Dec 31, 2019236.00K-264.00K-52.80%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Procaps Group 414.10M
Spero Therapeutics 106.46M
Atara Biotherapeutics 100.44M
InterCure 72.42M
bluebird bio 53.12M
Hyperfine 13.26M
X4 Pharmaceuticals 1.12M
Pheton Holdings 572.29K
Revenue Rankings

ENTX News

More News